Valerio Therapeutics bids €30M for Etherna Immunotherapies

July 1, 2026 3:22 AM EDT Send to a Friend
Valerio Therapeutics (Euronext Growth Paris: ALVIO) has signed a binding offer to acquire 100% of the share capital of Etherna ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login